T2 Biosystems Announces Presentations At ASM Microbe 2016
LEXINGTON, Mass., June 8, 2016 -- T2 Biosystems, Inc. (NASDAQ: TTOO), a company developing innovative diagnostic products to improve patient health, today announced the T2Candida® Panel will be the focus of a company symposium, one slide session and three poster presentations during ASM Microbe 2016, integrating the American Society of Microbiology’s two premier events, the General Meeting and the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). The annual meeting will take place June 16-20 in Boston.
The schedule for presentations by T2 Biosystems and its collaborators is as follows:
COMPANY SYMPOSIUM: “Sepsis Diagnosis: It’s Time for a New Gold Standard”
Date/Time: Friday, June 17 from 7 – 9 p.m.
Location: Westin, Grand Ballroom B
Overview: A discussion among leading experts who will share real clinical experiences with the T2Candida Panel to improve patient outcomes and cost management, as well as examine other diagnostic tests in development.
SLIDE SESSION: “Early Experience with T2Candida and Antifungal Utilization at a Large Community Health System”
Sponsored By: Lee Memorial Health System
Time: Sunday, June 19 from 3:30 - 3:45 p.m.
Location: Renaissance, Pacific Grand Ballroom F
POSTER PRESENTATION: “Performance Evaluation of the T2Candida Panel in the ICU Setting - Data from an Ongoing Study”
Sponsored By: Statens Serum Institut
Time: Monday, June 20 from 12:30 – 2:30 p.m.
Location: BCEC, Exhibit and Poster Hall, Halls A and B
POSTER PRESENTATION: “Verification of T2Candida Panel for the Identification of Candida Species in EDTA-preserved Whole Blood”
Sponsored By: Geisinger Health System
Time: Monday, June 20 from 12:30 – 2:30 p.m.
Location: BCEC, Exhibit and Poster Hall, Halls A and B
POSTER PRESENTATION: “Evaluation of BacT/Alert FA Blood Culture Bottles and T2Candida Assay for Detection of Candida in the Presence of Antifungals”
Sponsored By: University of Houston: College of Pharmacy
Time: Monday, June 20 from 12:30 - 2:30 p.m.
Location: BCEC, Exhibit and Poster Hall, Halls A and B
About T2 Biosystems
T2 Biosystems is focused on developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. T2MR enables the fast and sensitive detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, eliminating the time-consuming sample prep required in current methods. For more information, please visit www.t2biosystems.com.
The schedule for presentations by T2 Biosystems and its collaborators is as follows:
COMPANY SYMPOSIUM: “Sepsis Diagnosis: It’s Time for a New Gold Standard”
Date/Time: Friday, June 17 from 7 – 9 p.m.
Location: Westin, Grand Ballroom B
Overview: A discussion among leading experts who will share real clinical experiences with the T2Candida Panel to improve patient outcomes and cost management, as well as examine other diagnostic tests in development.
SLIDE SESSION: “Early Experience with T2Candida and Antifungal Utilization at a Large Community Health System”
Sponsored By: Lee Memorial Health System
Time: Sunday, June 19 from 3:30 - 3:45 p.m.
Location: Renaissance, Pacific Grand Ballroom F
POSTER PRESENTATION: “Performance Evaluation of the T2Candida Panel in the ICU Setting - Data from an Ongoing Study”
Sponsored By: Statens Serum Institut
Time: Monday, June 20 from 12:30 – 2:30 p.m.
Location: BCEC, Exhibit and Poster Hall, Halls A and B
POSTER PRESENTATION: “Verification of T2Candida Panel for the Identification of Candida Species in EDTA-preserved Whole Blood”
Sponsored By: Geisinger Health System
Time: Monday, June 20 from 12:30 – 2:30 p.m.
Location: BCEC, Exhibit and Poster Hall, Halls A and B
POSTER PRESENTATION: “Evaluation of BacT/Alert FA Blood Culture Bottles and T2Candida Assay for Detection of Candida in the Presence of Antifungals”
Sponsored By: University of Houston: College of Pharmacy
Time: Monday, June 20 from 12:30 - 2:30 p.m.
Location: BCEC, Exhibit and Poster Hall, Halls A and B
About T2 Biosystems
T2 Biosystems is focused on developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. T2MR enables the fast and sensitive detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, eliminating the time-consuming sample prep required in current methods. For more information, please visit www.t2biosystems.com.